All In Biotech

Drug Trial Radar · NCT01631474

A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety and Efficacy of Cortexolone 17a-Propionate (CB-03-01) Cream Applied Once or Twice-Daily for 12 Weeks in Subjects With Facial Acne Vulgaris

Last checked: Nov 19, 2026Latest source record: Nov 16, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 363 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

363

Actual

Start

Jun 2012

Primary completion

Feb 2014

Study completion Feb 2014

Sponsor

Lead sponsor
Intrepid Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jun 29, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

CB-03-01 is being developed for the topical treatment of acne vulgaris, an androgen-dependent skin disorder. The purpose of this study is to compare the safety and efficacy of multiple concentrations of CB-03-01 to vehicle in the treatment of acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

  • CB-03-01Drug

    Topical cream, applied once a day

  • VehicleDrug

    Topical cream, applied once or twice a day

  • CB-03-01Drug

    Topical cream, applied twice a day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Investigator's Global Assessment (IGA) "Success" - Week 12Time frame: Baseline and Week 12
  2. Inflammatory and Non-Inflammatory Lesion Counts - Week 12Time frame: Baseline and Week 12

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Dermatology Research Associates

    Los Angeles, California

  • Therapeutics Clinical Research

    San Diego, California

  • University Clinical Trials

    San Diego, California

  • International Clinical Research - US, LLC

    Sanford, Florida

  • Gwinnett Clinical Research Center, Inc.

    Snellville, Georgia

  • Altman Dermatology Associates

    Arlington Heights, Illinois

  • Indiana Clinical Trials Center

    Plainfield, Indiana

  • Marina I. Peredo, M.D., PC

    Smithtown, New York

  • Penn State Milton S. Hershey Medical Center - Dept. of Dermatology

    Hershey, Pennsylvania

  • Clinical Partners, LLC

    Johnston, Rhode Island

  • J & S Studies

    College Station, Texas

  • UT Houston Health Science Center

    Houston, Texas

  • Virginia Clinical Research

    Norfolk, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.